These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8934107)

  • 1. Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. The Fragmin Multicentre Study Group.
    Flordal PA; Berggvist D; Burmark US; Ljungström KG; Törngren S
    Eur J Surg; 1996 Oct; 162(10):783-9. PubMed ID: 8934107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.
    Agnelli G; Bergqvist D; Cohen AT; Gallus AS; Gent M;
    Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.
    Kucher N; Leizorovicz A; Vaitkus PT; Cohen AT; Turpie AG; Olsson CG; Goldhaber SZ
    Arch Intern Med; 2005 Feb; 165(3):341-5. PubMed ID: 15710801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT; Hunt N; Strachan RK; Nicolaides AN
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin.
    Partsch H; Kechavarz B; Köhn H; Mostbeck A
    Int Angiol; 1997 Sep; 16(3):189-92. PubMed ID: 9405014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting failure of low-dose prophylactic heparin in general surgical procedures.
    Wille-Jørgensen P; Ott P
    Surg Gynecol Obstet; 1990 Aug; 171(2):126-30. PubMed ID: 2382189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thrombo-embolic risk in surgery.
    Hoffmann R
    Hepatogastroenterology; 1991 Aug; 38(4):272-8. PubMed ID: 1937369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of heparin prophylaxis and bleeding complications in hysterectomy a nationwide prospective cohort study of 9,949 Danish women.
    Hansen CT; Kehlet H; Møller C; Mørch L; Utzon J; Ottesen B
    Acta Obstet Gynecol Scand; 2008; 87(10):1039-47. PubMed ID: 18792841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
    Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
    J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis.
    Holmström M; Aberg W; Lockner D; Paul C
    Thromb Haemost; 1999 Oct; 82(4):1222-6. PubMed ID: 10544902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.